Literature DB >> 27853201

The effects of Δ9-tetrahydrocannabinol on the dopamine system.

Michael A P Bloomfield1,2,3,4,5, Abhishekh H Ashok1,2,4, Nora D Volkow6, Oliver D Howes1,2,4.   

Abstract

The effects of Δ9-tetrahydrocannabinol (THC), the main psychoactive ingredient in cannabis, are a pressing concern for global mental health. Patterns of cannabis use are changing drastically owing to legalization, the availability of synthetic analogues (commonly termed spice), cannavaping and an emphasis on the purported therapeutic effects of cannabis. Many of the reinforcing effects of THC are mediated by the dopamine system. Owing to the complexity of the cannabinoid-dopamine interactions that take place, there is conflicting evidence from human and animal studies concerning the effects of THC on the dopamine system. Acute THC administration causes increased dopamine release and neuron activity, whereas long-term use is associated with blunting of the dopamine system. Future research must examine the long-term and developmental dopaminergic effects of THC.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27853201      PMCID: PMC5123717          DOI: 10.1038/nature20153

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  134 in total

1.  The European Monitoring Centre for Drugs and Drug Addiction publishes the European Drug Report 2013: trends and developments.

Authors: 
Journal:  Euro Surveill       Date:  2013-05-30

2.  Chronic marijuana smoke exposure in the rhesus monkey. IV: Neurochemical effects and comparison to acute and chronic exposure to delta-9-tetrahydrocannabinol (THC) in rats.

Authors:  S F Ali; G D Newport; A C Scallet; M G Paule; J R Bailey; W Slikker
Journal:  Pharmacol Biochem Behav       Date:  1991-11       Impact factor: 3.533

3.  Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu1 opioid receptor mechanism.

Authors:  G Tanda; F E Pontieri; G Di Chiara
Journal:  Science       Date:  1997-06-27       Impact factor: 47.728

4.  Effects of chronic delta9-tetrahydrocannabinol on rat midbrain dopamine neurons: an electrophysiological assessment.

Authors:  X Wu; E D French
Journal:  Neuropharmacology       Date:  2000-01-28       Impact factor: 5.250

5.  Repeated exposure to delta 9-tetrahydrocannabinol reduces prefrontal cortical dopamine metabolism in the rat.

Authors:  J D Jentsch; C D Verrico; D Le; R H Roth
Journal:  Neurosci Lett       Date:  1998-05-01       Impact factor: 3.046

6.  Mesolimbic dopaminergic decline after cannabinoid withdrawal.

Authors:  M Diana; M Melis; A L Muntoni; G L Gessa
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-18       Impact factor: 11.205

7.  Anandamide levels in cerebrospinal fluid of first-episode schizophrenic patients: impact of cannabis use.

Authors:  F Markus Leweke; Andrea Giuffrida; Dagmar Koethe; Daniela Schreiber; Brit M Nolden; Laura Kranaster; Miriam A Neatby; Miriam Schneider; Christoph W Gerth; Martin Hellmich; Joachim Klosterkötter; Daniele Piomelli
Journal:  Schizophr Res       Date:  2007-06-13       Impact factor: 4.939

8.  The effects of delta 9-tetrahydrocannabinol on potassium-evoked release of dopamine in the rat caudate nucleus: an in vivo electrochemical and in vivo microdialysis study.

Authors:  J M Ng Cheong Ton; G A Gerhardt; M Friedemann; A M Etgen; G M Rose; N S Sharpless; E L Gardner
Journal:  Brain Res       Date:  1988-06-07       Impact factor: 3.252

9.  The test-retest reliability of 18F-DOPA PET in assessing striatal and extrastriatal presynaptic dopaminergic function.

Authors:  Mitul A Mehta; Oliver D Howes; Alice Egerton; Arsime Demjaha; Philip McGuire
Journal:  Neuroimage       Date:  2009-12-23       Impact factor: 6.556

10.  Drug vaping applied to cannabis: Is "Cannavaping" a therapeutic alternative to marijuana?

Authors:  Vincent Varlet; Nicolas Concha-Lozano; Aurélie Berthet; Grégory Plateel; Bernard Favrat; Mariangela De Cesare; Estelle Lauer; Marc Augsburger; Aurélien Thomas; Christian Giroud
Journal:  Sci Rep       Date:  2016-05-26       Impact factor: 4.379

View more
  79 in total

1.  Voluntary oral consumption of Δ9-tetrahydrocannabinol by adolescent rats impairs reward-predictive cue behaviors in adulthood.

Authors:  Lauren C Kruse; Jessica K Cao; Katie Viray; Nephi Stella; Jeremy J Clark
Journal:  Neuropsychopharmacology       Date:  2019-04-10       Impact factor: 7.853

Review 2.  Cannabis use and cannabis use disorder.

Authors:  Jason P Connor; Daniel Stjepanović; Bernard Le Foll; Eva Hoch; Alan J Budney; Wayne D Hall
Journal:  Nat Rev Dis Primers       Date:  2021-02-25       Impact factor: 52.329

Review 3.  Pharmacology and adverse effects of new psychoactive substances: synthetic cannabinoid receptor agonists.

Authors:  Eun Yong Chung; Hye Jin Cha; Hyun Kyu Min; Jaesuk Yun
Journal:  Arch Pharm Res       Date:  2021-04-02       Impact factor: 4.946

Review 4.  The why behind the high: determinants of neurocognition during acute cannabis exposure.

Authors:  Johannes G Ramaekers; Natasha L Mason; Lilian Kloft; Eef L Theunissen
Journal:  Nat Rev Neurosci       Date:  2021-05-27       Impact factor: 34.870

5.  Astrocytic Mechanisms Involving Kynurenic Acid Control Δ9-Tetrahydrocannabinol-Induced Increases in Glutamate Release in Brain Reward-Processing Areas.

Authors:  Maria E Secci; Paola Mascia; Claudia Sagheddu; Sarah Beggiato; Miriam Melis; Andrea C Borelli; Maria C Tomasini; Leigh V Panlilio; Charles W Schindler; Gianluigi Tanda; Sergi Ferré; Charles W Bradberry; Luca Ferraro; Marco Pistis; Steven R Goldberg; Robert Schwarcz; Zuzana Justinova
Journal:  Mol Neurobiol       Date:  2018-08-27       Impact factor: 5.590

Review 6.  Interaction of Cannabis Use and Aging: From Molecule to Mind.

Authors:  Hye Bin Yoo; Jennifer DiMuzio; Francesca M Filbey
Journal:  J Dual Diagn       Date:  2019-09-30

7.  Psychosis-Relevant Effects of Intravenous Delta-9-Tetrahydrocannabinol: A Mega Analysis of Individual Participant-Data from Human Laboratory Studies.

Authors:  Suhas Ganesh; Jose Cortes-Briones; Mohini Ranganathan; Rajiv Radhakrishnan; Patrick D Skosnik; Deepak Cyril D'Souza
Journal:  Int J Neuropsychopharmacol       Date:  2020-12-03       Impact factor: 5.176

Review 8.  Cannabinoids in Pain Treatment: An Overview.

Authors:  Theresa Mallick-Searle; Barbara St Marie
Journal:  Pain Manag Nurs       Date:  2019-04       Impact factor: 1.929

9.  Delta-9 THC can be detected and quantified in the semen of men who are chronic users of inhaled cannabis.

Authors:  Malinda S Lee; Andrea Lanes; Elizabeth S Ginsburg; Janis H Fox
Journal:  J Assist Reprod Genet       Date:  2020-04-30       Impact factor: 3.412

Review 10.  Medications for substance use disorders (SUD): emerging approaches.

Authors:  Eduardo R Butelman; Mary Jeanne Kreek
Journal:  Expert Opin Emerg Drugs       Date:  2017-10-30       Impact factor: 4.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.